Catalyst Wire Dossier Catalyst Wire Dossier

PARI LC Sprint Sp Nebulizer

· PARI GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PARI LC Sprint Sp Nebulizer, covering 2017-02-01 to 2017-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age [NA]

See pricing